17 patients with SSc (85%) were positive for both ANA and anti-ENA, while 29 patients with RP secondary to suspected CTD (52.7%) were positive for ANA and 22 for anti-ENA (40%). This evidence concerns the gene ENAH and systemic sclerosis.